Events | GWG 2017 Conference | Speakers


Joel Bader

Mistakes Were Made

Maciej Maselko

Engineering Species-Like Barriers: A New Paradigm for Genetic Biocontainment and Biocontrol

Kelsie Becklin

Validation of Osteosarcoma Oncogenes Using a Medium Throughput Screen

Emily Camilleri

Sleeping Beauty Transposon Mutagenesis Screen for Chemotherapy Resistance Mechanisms in Osteosarcoma

Nicholas Slipek

CRISPR/Cas9 Screen for TSGs in Osteosarcoma

Kyle Williams

Exploiting Novel Vulnerabilities in NF1-Associated Tumorigenesis: A Small Molecule Screen Identifies Compounds Capable of Selectively Killing NF1 Deficient Human Schwann Cells

Gabriel Martínez-Gálvez

MEDJED – A Method for Predicting Microhomology-Mediated End Joining (MMEJ) Activation and Editing Outcomes

Hind Fadel

Investigating HIV-host Factors Interaction Using Genome Engineering

Emily Pomeroy

CRISPR/Cas9 Editing of Human Primary NK Cells for Preclinical Ovarian Cancer Therapy

Szu-Yi Hsu

Re-designing Natural Product Biosynthesis in Streptomyces

Douglas Corley

Biotechnology in China

Perry Hackett

The Promises and Uncertainties of Genome Editing in Animals in the 21st Century

Aidas Nasevicius

Glo-ing the Distance in Animal Biotechnology

Keynote Speaker: David Brin

Hard choices in Human Genetic Engineering

Karl Clark

Genome Engineering Provides Clues to Medical Mysteries Shortening the Diagnostic Odyssey

Jordan Welker

pGTAG and pPRISM: Two Expanded Tool Sets for Using Short Regions of Homology for Precise DNA Integration in CRISPR Compatible Systems

Aron Geurts

Transforming a Laboratory Species Through Genome Engineering

Stephen Ekker

Modifying the Powerhouse of the Cell

Jeffery Essner

Using Short Regions of Homology for Precise DNA Integration in Zebrafish

Mark Behlke

High Fidelity Genome Editing Using RNP Complexes with a Novel Mutant HiFi Cas9

Amber St. Martin

Single Nucleotide Editing Using Chimeric APOBEC-Cas9 Complexes

Eric Hendrickson

The Mechanisms of Precise Genome Editing Using Oligonucleotide Donors

Dr. David Brown

Midwest GWG Consortia Planning

Tammy Lee Stanoch

Public Perceptions

Leili Fatehi

Re-engineering Ethics: The Need for Ethics and Governance Innovation at the Convergence of Engineering and the Life Science

Alexandra J. Greenberg

Gene Editing & the Path Forward: Thoughts From a Translational Integrator

Neil Hoffman

Regulatory Thoughts

Junqi Liu

An Improved Method for Investigating Gene Functions in Soybean Roots Using CRISPR/Cas9 and Composite Plants

Shaun Curtin

CRISPR/Cas9 Mediated Mutagenesis of Soybean, Medicago and Wheat Crops

Alaa Koleilat

Using Genome Editing to Make Zebrafish Disease Models of Hearing Loss

Sara Isakson

The Genetically Engineered Minipig as a Preclinical Model of Neurofibromatosis Type I Syndrome-Associated Nervous System Tumors

Emily Julik

Lethal Mutagenesis of HIV-1 Induced by 5-aza-2’-Deoxycytidine in Human Primary CD4+ T Cells

Alex Larsson

TraSiR: Designing a Trans-Splicing Reporter to Detect Genetic Edits in Living Cells

Hirotaka Ata

Deciphering Logics for Activating Microhomology-Mediated End Joining In-vivo

Laurence Cooper

Harnessing the Immune System From the Bench to Bedside to Boardroom

Madhusudan V. Peshwa

Autologous Gene-corrected Hematopoietic Stem Cells as Potential Treatment for X-linked Chronic Granulomatous Disease

Julianne Smith

Waging War Against Cancer Through Genome Engineering

Congressman Emmer

David Largaespada

Tracking Down Cancer Using Transposon Mutagenesis and Targeted Nucleases

Lisa Koodie

Adenovirus-Based Radioiodine Therapy and Imaging for Pancreatic Cancer

Maura McGrail

Editing the Editors: Targeting Transcriptional Regulators in RB Tumor Suppression

Alan Marmorstein

Engineering iPSC to Novel Therapeutics for Eye Diseases

Caitlin Van Lith

Ex Vivo Hepatocyte-Directed Gene Repair in a Mouse Model of Metabolic Liver Disease

Scott McIvor

Gene Transfer and Genome Engineering Strategies for Therapy of Metabolic Disease